Use of agomelatine to obtain medication aimed at treating Smith-Magenis syndrome

Use of agomelatine to obtain medication aimed at treating Smith-Magenis syndrome

  • CN 101,194,901 A
  • Filed: 11/23/2007
  • Published: 06/11/2008
  • Est. Priority Date: 11/24/2006
  • Status: Active Application
First Claim
Patent Images

1. agomelatine or N-[2-(7-methoxyl group-1-naphthyl) ethyl] acetamide or its hydrate, crystal form and be used for the treatment of purposes in the syndromic medicine of Smith-Magenis in preparation with one of addition salts of pharmaceutically useful acid or alkali.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×